- Home
- NRIX vs BANR Comparison
NRIX vs BANR Comparison
Compare NRIX & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIX | BANR |
|---|---|---|
| Founded | 2009 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NRIX | BANR |
|---|---|---|
| Price | $25.65 | $70.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | $30.50 | ★ $70.00 |
| AVG Volume (30 Days) | ★ 1.0M | 249.5K |
| Earning Date | 04-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.14% |
| EPS Growth | N/A | ★ 15.57 |
| EPS | N/A | ★ 3.03 |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | N/A | $0.73 |
| Revenue Next Year | $48.05 | $5.69 |
| P/E Ratio | ★ N/A | $23.41 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.20 | $57.05 |
| 52 Week High | $28.23 | $74.84 |
Technical Indicators
Market Signals| Indicator | NRIX | BANR |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 49.47 |
| Support Level | $24.95 | $62.40 |
| Resistance Level | $28.23 | $72.65 |
| Average True Range (ATR) | 1.02 | 1.22 |
| MACD | -0.16 | -0.01 |
| Stochastic Oscillator | 40.83 | 57.76 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho, and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.